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1. Introduction
High intensity focused ultrasound (HIFU), or focused ultrasound surgery (FUS), is a non-invasive technique 
that is used to generate coagulative necrosis through localised thermal ablation in subcutaneous tissues (ter Haar 
1995). The main application area for HIFU has been in the treatment of soft tissue tumours (Kennedy 2005, 
Zhang and Wang 2010), such as liver, kidney (Illing et al 2005), breast (Peek et al 2014), prostate (Blana et al 
2008), and brain (Coluccia et al 2014). HIFU has also been used in the treatment of bone tumours (Rodrigues 
et al 2015), and its uses are expanding into new areas such as the treatment of neurological disorders (Wang et al 
2015) and pain management (Brown et al 2015). Clinical uses of HIFU generally use either magnetic resonance 
imaging (MRI) (Hynynen 2010) or diagnostic ultrasound (US) imaging (Kennedy et al 2004) for treatment 
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Abstract
High intensity focused ultrasound (HIFU) or focused ultrasound surgery is a non-invasive technique 
for the treatment of cancerous tissue, which is limited by difficulties in getting real-time feedback 
on treatment progress and long treatment durations. The formation and activity of acoustic 
cavitation, specifically inertial cavitation, during HIFU exposures has been demonstrated to enhance 
heating rates. However, without the introduction of external nuclei its formation an activity can be 
unpredictable, and potentially counter-productive.
In this study, a combination of pulse laser illumination (839 nm), HIFU exposures (3.3 MHz) 
and plasmonic gold nanorods (AuNR) was demonstrated as a new approach for the guidance and 
enhancement of HIFU treatments. For imaging, short duration HIFU pulses (10 μs) demonstrated 
broadband acoustic emissions from AuNR nucleated cavitation with a signal-to-noise ranging 
from 5–35 dB for peak negative pressures between 1.19–3.19  ±  0.01 MPa. In the absence of either 
AuNR or laser illumination these emissions were either not present or lower in magnitude (e.g. 
5 dB for 3.19 MPa). Continuous wave (CW) HIFU exposures for 15 s, were then used to generate 
thermal lesions for peak negative pressures from 0.2–2.71  ±  0.01 MPa at a fluence of 3.4 mJ cm−2. 
Inertial cavitation dose (ICD) was monitored during all CW exposures, where exposures combined 
with both laser illumination and AuNRs resulted in the highest level of detectable emissions. This 
parameter was integrated over the entire exposure to give a metric to compare with measured 
thermal lesion area, where it was found that a minimum total ICD of 1.5 × 103 a.u. was correlated with 
the formation of thermal lesions in gel phantoms. Furthermore, lesion area (mm2) was increased for 
equivalent exposures without either AuNRs or laser illumination.
Once combined with cancer targeting AuNRs this approach could allow for the future theranostic 
use of HIFU, such as providing the ability to identify and treat small multi-focal cancerous regions 
with minimal damage to surrounding healthy tissue.
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guidance. Both techniques have advantages and disadvantages when used for guidance, and are undergoing 
constant improvements in order to increase the use of HIFU in the clinic (Ebbini and ter Haar 2015).
In HIFU there are predominately two physical mechanisms resultant from exposures, which are thermal and 
cavitational. While thermal ablation is the primary consideration in the clinical use of HIFU, cavitation activity 
can play an important role (Shaw et al 2016). The general term of ‘cavitation activity’ covers a range of phenom-
ena that can be dependent on the exposure parameters and/or target medium. However, it is commonly defined 
as the presence and activity of acoustic cavitation (Neppiras 1980, 1984) and/or thermally mediated gas pocket 
formation, through exsolution or vaporisation (McLaughlan et al 2010a). Acoustic cavitation is characterised by 
two types of bubble behaviour, non-inertial (stable) and inertial (transient) (Leighton 1994). The presence of 
cavitation activity can be both advantageous, through enhanced localised heating (Hynynen 1991, Holt and Roy 
2001) or disadvantageous, due to over-treatment of regions and causing asymmetrical regions of thermal abla-
tion (Watkin et al 1996, Meaney et al 2000). For HIFU exposures where the target medium is heated it is not gen-
erally possible to make a clear distinction between the type of cavitation activity occurring. Nevertheless, when 
the duty cycle is reduced to neglect any effects from heating, the peak negative pressure (P−) required to generate 
detectable acoustic cavitation activity is typically greater than 10 MPa (Gateau et al 2011, Arnal et al 2017). This 
approach termed histotripsy (Hall et al 2007) primarily relies on mechanical damage from bubble activity to 
cause tissue destruction without any significant heating to the tissue. Whereas the technique termed boiling his-
totripsy (Wang et al 2013) sits between the predominately thermal or mechanical approaches for localised tissue 
destruction.
Cavitation activity is commonly monitored using passive, or active cavitation detection (PCD or ACD). PCD 
systems typically have focused broadband detectors that are co-axially aligned or intersect with the HIFU focus, 
to monitor acoustic emissions generated by cavitation activity during exposures (Coussios et al 2007). ACD type 
of detection allows analysis of the spectral content within emissions, in order to indicate the type of cavitation 
activity present (McLaughlan et al 2010a). As non-inertial and inertial cavitation can both generate subharmon-
ics ( f0/n) (Neppiras 1980), where f0 is the HIFU drive frequency and n is a positive integer. Superharmonic emis-
sions (nf0), are generally indicative of non-linear oscillations of non-inertial cavitation (Miller 1981), but are 
rarely used due to the difficulty in separating them from harmonics generated by non-linear propagation of the 
HIFU field (Meaney et al 2000, Leighton 2007). Ultraharmonic emissions ((2n + 1) f0/n), are thought to be also 
generated by non-linear oscillations of either non-inertial or inertial cavitation (Basude and Wheatley 2001). It 
is only broadband emissions generated from the collapse of inertial cavitation (Neppiras 1969) that are unique 
identifiers of specific bubble behaviour. Recently, the use of transducer arrays that operate in a passive mode with 
dedicated beamforming techniques have been used to produce cavitation maps of exposed regions (Salgaonkar 
et al 2009, Gyongy and Coussios 2010). Although these systems are commonly used for in vitro and in vivo stud-
ies, they are rarely used in conjunction with clinical uses of HIFU. ACD systems are commonly diagnostic ultra-
sound systems that are used to image the exposed regions before, immediately after or interleaved with the HIFU 
exposures (Vaezy et al 2001, Illing et al 2005, Khokhlova et al 2006, Farny et al 2009, McLaughlan et al 2010a). This 
provides a direct visualisation of a hyperechogenic region and has been used to guide clinical treatments (Wu 
et al 2007), but could lead to an overestimation of the treated area, since hyperechogenicity and the thermal dam-
age do not necessarily correlate (Vaezy et al 2001).
The introduction of external nuclei, such as microbubbles (He et al 2011, Blum et al 2016) or phase-shift 
nanoemulsions (Zhang and Wang 2010, Zhao et al 2016) have been shown to decrease the pressure thresholds 
needed to generate cavitation from HIFU exposures, which can result in better visualisation of the treated region 
and/or enhanced thermal ablation. HIFU can also be used to aid in the release and/or delivery of a diagnostic, 
therapeutic, or theranostic agent (Park et al 2013, Zheng et al 2016, Lee et al 2017) to a targeted region. Plasmonic 
gold nanoparticles (Huang et al 2008), are one of a range of nanomedicines (Caster et al 2017) that can be com-
bined with HIFU in order to increase therapeutic potential (Etame et al 2012, Devarakonda et al 2017).
Photoacoustic imaging (PAI) is a non-invasive and non-ionising imaging technique that combines the spec-
tral selectivity of pulsed laser excitation with the high resolution of ultrasound imaging (Wang and Hu 2012). 
This technique is used clinically, but is generally limited to superficial imaging (McNally et al 2016, Taruttis et al 
2016). PAI has previously been used to guide HIFU exposures (Cui and Yang 2010). As the amplitude of the 
broadband acoustic emissions generated through PAI are directly proportional to the absorbed laser fluence 
(Diebold et al 1991), the maximum permissible exposure (MPE) (ANSI 2007) for the illuminating laser sys-
tem will limit this technique. Gold nanoparticles (AuNPs) can be used in conjunction with PAI to help increase 
contrast in regions where they aggregate in sufficient quantity (Li et al 2008, Li and Chen 2015, Ye et al 2015). If 
AuNPs are exposed to a sufficiently high laser fluence it is possible to generate small vapour bubbles (Lapotko 
2009), which can be used for highly localised imaging (Lukianova-Hleb et al 2016). Simultaneously exposing 
AuNPs to both laser illumination and an ultrasound field has been shown to reduce the laser fluence and acoustic 
pressure needed to nucleate small vapour bubbles, which has been shown to enhance photoacoustic imaging 
(McLaughlan et al 2010b), and the ability to controllably create cavitation activity for HIFU applications (Farny 
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et al 2005, Ju et al 2013). In the absence of external particles it has been shown that combining HIFU with pulse 
laser exposure can result in enhancement of lesion formation (Cui and Yang 2011, Jo and Yang 2016). However, in 
these studies the presence of the thermocouple near the focal peak may had reduced the local cavitation thresh-
old.
In this paper a combination of pulse laser illumination combined with HIFU exposures and plasmonic 
AuNPs was demonstrated as a new approach for the enhancement of HIFU treatments using a highly control-
lable technique for the nucleation of cavitation activity. Importantly it demonstrates in in vitro models that using 
very short duration HIFU exposures can be used to generate detectable broadband acoustic emissions from 
AuNP nucleated vapour bubbles, which can be used for imaging. Furthermore, by simply increasing the dura-
tion of these exposures with the same system it was shown that the thermal denaturation from continuous wave 
(CW) HIFU exposures were greatly enhanced when combining these three techniques.
2. Methods
2.1. Nanoparticles, HIFU and laser system
A single element HIFU transducer (H-102, Sonic Concepts, WA, USA) driven at its third harmonic of 3.3 MHz 
was used to perform all in vitro exposures. This transducer was connected to a 55 dB power amplifier (A300, 
E&I Ltd, NY, USA) via an impedance matching circuit, as shown in figure 1(a). A computer controlled function 
generator (33250A, Keysight Technologies UK Ltd, Berkshire, UK) was used to provide either a 10 cycle burst 
(3 μs) with a pulse repetition frequency (PRF) of 10 Hz, or a 15 s duration CW exposure. The free-field acoustic 
pressure output of this system was measured using a differential membrane hydrophone (Precision Acoustics 
Ltd, Dorchester, UK) with a 400 μm sensitive element that had been calibrated by the National Physical 
Laboratory (Middlesex, UK). All pressure measurements quoted in this study had an uncertainty of  ±0.1 MPa. 
This value was obtained by combining the standard deviation of the pressure measurement for three repeat, with 
the uncertainty parameters provided by NPL for the membrane hydrophone used. Synchronisation between the 
HIFU and laser systems was achieved using a TTL digital delay pulse generator (9524, Quantum Composers, MT, 
USA), which ensured that the 7 ns laser pulse was coincident in the target region during the fourth rarefaction 
peak from the HIFU transducer. A Nd:YAG 532 nm laser (Surelite I-10, Continuum, CA, USA) was used to pump 
an optical parametric oscillator (Surelite OPO Plus, Continuum, CA, USA) to tune the output wavelength. The 
laser output was coupled into a 2 mm optical fibre bundle (BF20LSMA01, Thorlabs Inc, NJ, USA) that provided a 
15 mm spot size in the target region. An energy sensor (ES145C, Thorlabs Inc, NJ, USA) was used to calibrate the 
energy in the laser pulse, which was controlled by adjusting the timing between the laser flash lamp firing and the 
Q-switch. All fluence values quoted in this study had an uncertainty of  ±0.1 mJ cm−2.
Citrate capped gold nanorods (AuNRs) were used (A12-40-850, Nanopartz Inc, CO, USA) for this study. 
A transmission electron microscope (Tecnai,TF20, FEI, USA) was used to take images of the AuNRs, as shown 
in figure 1(b). The surface plasmon resonance (SPR) of this particle population was established by measuring 
their absorbance spectrum using a UV-Vis spectrometer (Gensys 20, Thermo Fisher Scientific, MA, USA), which 
established the SPR to be 839  ±  2 nm (figure 1(c)). As such, the laser was tuned to this specific wavelength for all 
exposures in this study.
2.2. Passive cavitation detection system
A broadband focused detector (Y-102, Sonic Concepts, WA, USA) installed and co-aligned in the central aperture 
of the HIFU transducer, was used to detect the acoustic emissions generated in this study (figure 1(a)). This 
detector was connected to a 5 MHz high pass filter (Allen Avionics, NY, USA) in order to suppress detection of the 
HIFU drive frequency before connection to a 40 dB pre-amplifier (SPA.1411, Spectrum GmbH, Grosshansdorf, 
Germany). A 14-bit data acquisition (DAQ) card (M4i.4420-×8, Spectrum GmbH, Grosshansdorf, Germany) 
was used to record acoustic emissions during exposures. This card was installed inside a desktop PC which was 
used to control all hardware and save the data for off-line processing using MatLab (Mathworks Inc, MA, USA). 
For the short pulses the signal-to-noise (SNR) level was calculated on a windowed region around the detected 
acoustic emissions in the time domain. The SNR was reference to a noise measurement made using the detection 
system without either HIFU or laser exposures, and calculated using MatLab’s SNR function. For CW exposures 
the ‘cavitation dose’ (Chen et al 2003) was calculated by recording data for 17 s, which was then subdivided 
into approximately 100 μs segments that were frequency analysed and comb-filtered to remove super- and 
ultraharmonics (McLaughlan et al 2010a) leaving only broadband emissions. This filtered spectra was integrated 
between 5–20 MHz to produce the cavitation dose as a function of time. Data was recorded for 1 s immediately 
prior and post the 15 s HIFU exposure. The total inertial cavitation dose (ICD) was calculated by integrating this 
signal over the 15 s exposure duration.
Phys. Med. Biol. 63 (2018) 015004
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2.3. Temperature sensitive tissue-mimicking phantoms
An optically transparent tissue-mimicking phantom material was used for all exposures in this study (Lafon 
et al 2005, Choi et al 2013). This temperature sensitive phantom was made by mixing degassed, deionised and 
filtered water (60% v/v) with 40% Acrylamide/Bis-acrylamide solution (A9926, Sigma Aldrich UK, Dorset, 
UK) (30% v/v), followed by 1 mol/L TRIS buffer (T2694, Sigma Aldrich UK, Dorset, UK) (10% v/v). Next 10% 
ammonium persulfate (APS) solution (A3678, Sigma Aldrich UK, Dorset, UK) (0.84% v/v) was added to initiate 
polymerisation when the catalyst was added. The solution was placed inside a vacuum chamber on a magnetic 
stirring plate for addition of the bovine serum albumin (BSA) (A7906, Sigma Aldrich UK, Dorset, UK) (7% w/v), 
where it was maintained under vacuum for 60 min to further degas the phantom solution and ensure the BSA was 
fully mixed. Finally, where required, the AuNRs were added to the solution at a concentration of 1 × 108 NR ml−1 
and allowed to fully mix with the solution before the catalyst, TEMED (T9281, Sigma Aldrich UK, Dorset, UK) 
(0.05% v/v) was added. This final solution was then poured into the moulds and left to polymerise, after which 
they were immediately used for experiments. The phantom dimensions from this mould were 26 × 19 × 89 
mm, and were placed inside a custom 3D printed (Robox, CEL-UK, Bristol, UK) holder that was mounted on a 
computer controlled 3-axis positioning system (Zolix, Beijing, China), as shown in figure 1(a), and all exposures 
were performed in different locations in the phantoms. This holder allowed for direct optical and/or acoustic 
access from four sides. Printable files for the mould and holder have been included in the supplementary material 
(S1) (stacks.iop.org/PMB/63/015004/mmedia). A matched pair of weakly focused ultrasound transducers with 
a centre frequency of 3.5 MHz (V384, Olympus Industrial, Essex, UK), were used to measure the attenuation 
coefficient at the HIFU drive frequency. The attenuation was measured (Bush et al 1993) using short duration 
broadband pulses (5077PR, Olympus Industrial, Essex, UK) propagating through either water, or phantoms 
with/without AuNRs. The attenuation (n = 5) at 3.3 MHz was found to be 0.43  ±  0.14 and 0.70  ±  0.20 
dB cm−1 for phantoms without and with AuNRs, respectively. A one way ANOVA test was used to demonstrate 
that this increase in attenuation for the AuNR phantoms was statistically significant, p = 0.044. As these 
phantoms contain BSA it has been shown that these proteins will undergo denaturation above 50 °C (Lafon et al 
2005), and will turn from opaque to white.
A 20-90x magnification digital microscope (AM4113TL, Dino-lite, New Taipei City, Taiwan) was used to 
monitor the thermal lesion formation in the phantoms from the CW exposures. The microscope was positioned 
perpendicular to the direction of propagation to the HIFU field, where the dashed rectangle in figure 1(a) indi-
cates the imaging plane recorded with this microscope. Imaging frames from the microscope were saved directly 
in MatLab for off-line processing and the area of thermal lesion in the phantoms were measured manually in the 
frames immediately after the HIFU exposures. A 1 mm metallic spherical target was used to ensure alignment 
between the HIFU transducer, broadband detector, laser illumination and microscope was maintained. This 
alignment target was embedded in the centre of a gel phantom, where the HIFU transducer was localised on this 
location using pulse-echo. Once the HIFU transducer and co-aligned PCD was targeted on the alignment target, 
the laser was tuned to 680 nm (i.e. visible light) in order to align to this location. Finally, the microscope was then 
Figure 1. (a) A schematic of the experimental apparatus used. The hashed box indicates the region recorded using the USB 
microscope system, which has been omitted for clarity. (b) shows a TEM image of the gold nanorods used in this study, where the 
scale bar indicates 100 nm. (c) Averaged (n = 3) UV-Vis absorbance measurements of a population of the nanorods used.
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moved to focus this alignment target centrally in its image. Once this procedure was completed the alignment 
target was removed from the holder (S1) and replaced with the AuNR gel phantoms. This approach allowed for 
the phantoms to be moved using the automated stage, whilst retaining alignment between the experimental 
apparatus.
3. Results
3.1. Pulsed exposures for imaging
Figure 2 shows examples of the detected acoustic emissions with the PCD system. In this only with the 
combination of AuNRs, HIFU and laser illumination generated the broadband acoustic emissions that are 
associated with vapour bubble activity. In this example the laser fluence was 2.1 mJ cm−2, where applicable, with 
two different P−s (1.43 or 2.34 MPa). Where broadband emissions are present the two key differences were that for 
the larger pressure, both the duration and amplitude are increased, and the time of flight for these emissions both 
correspond to the synchronisation of the laser and HIFU pulses in the target region. Furthermore, the spectra 
shown in figures 2(g) and (h) show that some of the detected emissions might be due to scattered harmonics of 
the drive frequency (e.g. 6.6 MHz) (McLaughlan et al 2010a).
In figure 3, the averaged SNR was plotted as a function of P− for the four laser fluences of 0.4, 1.1, 2.1 and 3.4 
mJ cm−2. For all four fluence values it was only with the combination of HIFU, AuNRs and laser illumination 
that these pulsed exposures generated any significant broadband acoustic emissions. At a P− of 3.19 MPa the 
SNR was approximately 40 dB, irrespective of the laser fluence used. was reduced. For exposures in phantoms 
without either AuNRs or laser illumination, low levels of broadband acoustic was detected. In exposures with 
high variance between repeats the errorbars indicate a possibility of negative SNR, which was an artefact of using 
symmetrical errorbars.
3.2. CW exposures for thermal denaturation
The ICD (Chen et al 2003) was calculated for all CW exposures in the temperature sensitive gel phantoms. 
Figure 4 shows examples of these measurements for 15 s exposures at a P− of 1.69 or 2.13 MPa, with/without 
laser illumination and/or AuNRs present in the gel. In all these measurements 1 s of acoustic data was recorded 
immediately before and after the HIFU exposure. Inset images show the focal region immediately after the HIFU 
exposure, recorded using the digital microscope (full videos from each of these exposures can be found in the 
supplementary material, S2). As the microscope was positioned perpendicular to the acoustic axis (figure 1(a)) 
the view shows the axial/radial plane of the focal region, where the HIFU propagates from left to right in the 
image. Thermal lesions were observed in three of these exposures, two of which occurred (figures 4(c) and(f)) at 
both P−s with laser illumination and AuNRs present. The blue colour observed in the inset of figure 4 was due to 
an artefact caused by laser light scattering into the detector.
Figure 5 gives both the averaged total ICD and measured thermal lesion area for repeat exposures, with 
increasing P−s. Both the ICD and thermal lesion area was greatest for the HIFU exposures that had laser illumi-
nation and AuNRs present.
The theranostic potential of this technique was demonstrated in figure 6, where a small AuNR inclusion was 
embedded inside a larger gel phantom and raster scanned (figure 6(a)) using pulsed HIFU with a P− of 2.53 MPa, 
then at four locations (P1-4) a 15 s CW exposure was performed at a P− of 2.13 MPa. These locations were chosen 
from the imaging data to have two exposures inside and two outside of the AuNR inclusion (highlighted by a 
dashed red line in figure 6(b). Only exposures within this inclusion resulted in thermal lesion formation.
Figure 2. Example PCD data for single exposures with a laser fluence (where applicable) of 2.1 mJ cm−2, and peak negative 
pressures of ((a)–(c)) 1.43  ±  0.01 or ((d)–(f)) 2.34  ±  0.01 MPa. The normalised frequency spectra for each exposures at 1.43  ±  or 
2.34  ±  0.01 MPa, is shown in (g) and (h), respectively.
Phys. Med. Biol. 63 (2018) 015004
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4. Discussion
The use of molecular-targeted theranostic agents offers the potential for earlier identification and treatment 
of a wide range of cancers (Sneider et al 2017). These agents are typically activated by external stimuli, such as 
ultrasound or laser illumination. In this study we have demonstrated, in vitro, the capability of using AuNRs 
combined with HIFU and pulsed laser illumination for both imaging and enhanced thermal denaturation. The 
potential therapeutic uses for this approach are varied, but may include reduction of tumour mass to facilitate 
breast conservation surgery, local control after surgery especially when margins are small or compromised, or 
Figure 3. The averaged signal-to-noise measurements for pulsed exposures with HIFU, laser illumination (LS) and/or AuNRs 
(NR) for an increasing peak negative pressure. Four different laser fluences of (a) 0.4, (b) 1.1, (c) 2.1 and (d) 3.4 mJ cm−2 were used. 
Errorbars are the standard deviation (n = 3) for repeat measurements of equivalent exposure conditions in different phantoms.
Figure 4. Example PCD measurements for 15 s CW HIFU exposures at peak negative pressure of (top row) 1.69 or (bottom row) 
2.13  ±  0.01 MPa. The laser fluence was 3.4 mJ cm−2, where appropriate. The inset photographs show the cross-section of exposed 
phantom in the axial/radial direction with the HIFU field propagating from left to right, and spacing between the inset tick marks 
represent 0.5 mm.
Phys. Med. Biol. 63 (2018) 015004(11pp)
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even molecular profiling and non-invasive treatment of ductal carcinoma in situ (DCIS), where the treatment 
pathway is less well defined (Esserman and Yau 2015). Furthermore, when combined with cancer targeted 
AuNRs (such as anti-HER2) this approach could be used for highly localised HIFU ablation in small multi-focal 
cancers since this study demonstrates that a combination of HIFU, laser illumination and AuNR are required for 
enhanced thermal denaturation.
The same system was used for both the imaging and therapeutic aspects of this study (figure 1(a)), with only 
the exposure duration being the key difference. Example broadband emissions generated from the AuNR nucle-
ated vapour bubble activity were shown in figures 2(c) and (f), for these short duration exposures (3 μs). As these 
phantoms contained no addition ultrasound scatterers, such as glass particles (Choi et al 2013), the only acoustic 
emissions detected from these phantoms were those generated by acoustic cavitation. For the averaged datasets 
(figure 3) at all P− values where signals were detected, the broadband emissions generated when the AuNRs were 
simultaneously exposed to HIFU and laser illumination had the highest SNR values. In the four laser fluence 
levels shown, at the highest P− level (3.19 MPa), this value was 30 dB higher that emissions generated without 
either AuNRs present or laser illumination. Furthermore, when no HIFU was present (0 MPa exposure level) 
laser illumination of the AuNR region did not generate any detectable PA emissions, showing the enhancement 
this technique can provide over conventional PAI (McLaughlan et al 2010b). The MPE for this laser wavelength 
(839 nm) and pulse duration (7 ns) was 40 mJ cm−2 (ANSI 2007) and the lowest and highest fluences used in this 
study were 1 and 8.5% of this limit, which highlights the possible use of this technique for deeper applications 
than generally accessible for PAI (Dean-Ben et al 2017). For the lowest fluence level (figure 3(a)), the variation in 
the measurements was higher, which would suggest that this fluence of 0.4 mJ cm−2 was close to the nucleation 
threshold for vapour bubbles. However, as the laser fluence increases the P− required to generate detectable emis-
sions decreased. This was likely due to the fact that the initial laser illumination was only required for the nuclea-
tion of a small vapour region, which combined with the tension from the HIFU field results in the formation and 
activity of a vapour bubble. Once nucleated, the detected signal magnitudes for emissions were similar for the 
different P−, irrespective of the laser fluence used. Thus as it was the HIFU field that drives the inertial cavitation 
the SNR of this imaging technique would be determined by the amplitude of the HIFU field used, rather than 
the laser fluence. This remains a key difference with PAI where the PA emission is generally linearly dependent 
on the in situ laser fluence (Wang and Hu 2012), which suggests that this approach would have higher SNR over 
conventional PAI as ultrasound is less readily attenuated in tissue compared with near infra-red (NIR) light. If an 
effective attenuation coefficient of 0.21 mm−1 is assumed for breast tissue illuminated at 850 nm (Key et al 1991) 
this system would be able to image up to a depth of 22 mm. This depth could be further improved by optimis-
ing the illumination mechanism (Wang and Hu 2012). For deeper structures it would be possible to illuminate 
intraoperatively (Andrew et al 2016) , or a catheter light delivery system (Karpiouk et al 2010). Furthermore, the 
mechanical index (MI) (Apfel and Holland 1991) for the highest pressure level used was 1.76, which remains 
within the guidelines for the safe use of ultrasound (Barnett et al 2000). However, such safety guidelines have lim-
ited applicability in the use of AuNRs. The amplitude of the acoustic response for this imaging technique being 
dictated by the HIFU pressure level, rather than the laser fluence, means that it would be more sensitive to lower 
concentrations of AuNRs than PAI (Mallidi et al 2009).
The ICD was calculated for all CW exposures in the gel phantoms, examples of which are shown in figure 4. 
For all of these examples emissions were detected, but in the absence of either laser illumination or AuNRs these 
emissions were lower or more variable compared with when both of these were present. The inset image in 
figure 4(d) shows and example of a thermal lesion formed in an a HIFU exposure in a phantom without AuNRs. 
Figure 5. The averaged (a) total inertial cavitation dose, and (b) thermal lesion area for all CW HIFU exposures with, where 
appropriate, a laser fluence of 3.4 mJ cm−2. Errorbars are the standard deviation (n = 3) for repeat measurements of equivalent 
exposure conditions in different phantoms.
Phys. Med. Biol. 63 (2018) 015004
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For the example exposure in a phantom with AuNRs but no laser illumination (figure 4(e)), no thermal lesion 
was present. As the measured attenuation of the phantom material was slightly higher for those containing 
AuNRs (0.70  ±  0.20 dB cm−1), compared with those without (0.43  ±  0.14 dB cm−1) if the lesion formation was 
predominately thermal in nature the exposure shown in figure 4(e), should have generated a larger lesion. Nev-
ertheless, this was not the case, which would suggest that cavitation activity played a significant role in the forma-
tion of these thermal lesions. This highlights a limitation of this study, since the attenuation of the phantoms was 
lower than the expected 3–4 dB cm−1 (Duck 1990) attenuation of healthy breast tissue. The consequence of this 
would be to suppress thermal lesion formation in the absence of cavitation activity. Nevertheless, this issue was 
slightly mitigated through the use of a higher HIFU frequency (3.3 MHz) than would generally be used clinically 
(Hynynen and Jones 2016), making cavitation activity be less likely than would be expected at a lower frequency.
Aside from the use of MRI guided HIFU (Bour et al 2017) to monitor the localised temperature increase 
from exposures, there are no other real-time options for treatment guidance. When using ultrasound guidance 
interleaving between therapy and diagnostic exposures allows for the visualisation of the targeted region in the 
presence of cavitation activity (Rabkin et al 2005, 2006), but this can be a poor indicator of thermal damage 
(McLaughlan et al 2010a). Nevertheless real-time monitoring of the formation of thermal lesions from HIFU 
exposures represents a challenge for the widespread adoption of HIFU (Ebbini and ter Haar 2015). When using 
external nuclei for the formation of cavitation activity and heating enhancement it may also be possible to incor-
porate acoustic measurements that can be monitored during the HIFU exposure to aid with treatment moni-
toring. In figure 5 the averaged total ICD was recorded for all exposures, and the P− values when this parameter 
exceeded a value of 1.5 × 103 a.u., the formation of thermal lesions was observed for exposures with laser illumi-
nation (figure 5(b)). For the exposures that did not have laser illumination (e.g. figures 4(b) and (e) the thermal 
lesion areas were the smallest and the variability in the detected total ICD was high. This would suggest for these 
exposures that the cavitation activity was variable and does not have a significant impact on thermal lesion for-
mation. The qualitative agreement between the total ICD and thermal lesion formation for HIFU exposures that 
had laser illumination and AuNRs present suggests that this parameter could provide a useful metric with which 
to modulate exposure amplitudes/durations (Lai et al 2011).
Figure 6 illustrates the theranostic potential of this approach, with a small (5x10x5 mm) rectangular inclu-
sion in the a larger phantom. Both the phantom and inclusion were made with the procedure outlined in the 
methods, but with only the inclusion containing AuNRs. This could mimic a future clinical situation where 
AuNRs have been targeted (active or passive) to a region of interest, such as microcalcifications in DCIS (Cole 
et al 2015, Cen et al 2017). A 2D raster scan over the phantom identifies the small AuNR inclusion through the 
detection of broadband emissions (figures 4(c) and (f)), which was then targeted using CW exposures. From the 
four CW exposures taken in this example only the two that were located inside the inclusion generated a thermal 
Figure 6. (a) A 2D raster scan of a AuNR inclusion inside a tissue-mimicking phantom, with pulsed HIFU at a peak negative 
pressure of 2.53  ±  0.01 MPa and a laser fluence of 3.4 mJ cm−2. (b) The approximate dissected plan corresponding to the raster 
scan, with the locations of four identical HIFU exposures illustrated by dashed white circles. The red dashed rectangle highlights the 
bounds of the AuNR inclusion in the phantom.
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lesion, for equivalent exposure parameters. This demonstrates the possibility for this technique to be used for 
identifying tumorous regions then performing localised thermal denaturation on regions containing targeted 
AuNRs, which could cause minimal damage to healthy tissue.
5. Conclusion
By combining HIFU with AuNRs and pulsed laser illumination, controlled and repeatable generation of 
AuNRs nucleated inertial cavitation for both imaging and enhancing HIFU exposures, was demonstrated, in 
vitro. Broadband acoustic emissions were generated that can were used to image regions containing AuNRs. 
For pulsed HIFU exposures combined with AuNRs and laser illumination these emissions had a SNR 30 dB 
higher than exposures without one of these key components. Furthermore, this was achieved with laser fluences 
that were less than 8.5% of the maximum permissible exposure. Therapeutic potential was demonstrated 
through the generation of inertial cavitation enhanced thermal denaturation in tissue-mimicking phantoms, 
where the thermal lesion area was increased by 100% for some exposure conditions. Inertial cavitation dose was 
monitored during these exposures and showed some potential for providing real-time feedback in the success 
of exposures. This theranostic technique has the potential of overcoming limitations in HIFU treatments, by 
providing treatment guidance and monitoring with increasing thermal denaturation rates. Once combined with 
cancer targeting AuNRs the technique could be used for the treatment of small multi-focal cancerous regions 
with minimal damage to surrounding healthy tissue.
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